Topamax medication during pregnancy can lead to increased risk of oral birth defects in babies

New data suggest that the Topamax and its generic versions increase the risk for the birth defects cleft lip and cleft palate in babies born to women who use the medication during , the U.S. Food and Administration said today.


Read more

Related posts

Leave a Reply